Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients

Author:

Morris Nicolette T.,Brook Jenny,Ben-Artzi Ami,Martin William,Kermani Tanaz A.,Avedikian-Tatosyan Lynette,Karpouzas George,Nagam Himakar,Navarro Geraldine,Choi Soo,Taylor Mihaela B.,Elashoff David,Kaeley Gurjit S.,Ranganath Veena K.ORCID

Funder

genentech

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Reference24 articles.

1. Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J (2008) IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 67(11):1516–1523. https://doi.org/10.1136/ard.2008.092932

2. Strand V, Burmester GR, Ogale S, Devenport J, John A, Emery P (2012) Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study. Rheumatology (Oxford) 51(10):1860–1869. https://doi.org/10.1093/rheumatology/kes131

3. Smolen JS, Aletaha D (2011) Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Arthritis Rheum 63(1):43–52. https://doi.org/10.1002/art.27740

4. Chiu WC, Lai HM, Ko CH, Chen JF, Hsu CY, Chen YC (2018) Ultrasound is more reliable than inflammatory parameters to evaluate disease activity in patients with RA receiving tocilizumab therapy. J Investig Med 66(6):1015–1018. https://doi.org/10.1136/jim-2017-000705

5. Ranganath VK, Hammer HB, McQueen FM (2020) Contemporary imaging of rheumatoid arthritis: clinical role of ultrasound and MRI. Best Pract Res Clin Rheumatol 34(6):101593. https://doi.org/10.1016/j.berh.2020.101593

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3